Equities

Can Fite Biopharma Ltd

Can Fite Biopharma Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (ILa)242.10
  • Today's Change1.90 / 0.79%
  • Shares traded29.96k
  • 1 Year change-25.09%
  • Beta-0.4618
Data delayed at least 20 minutes, as of Jun 21 2018 15:24 BST.
More ▼

Key statistics

On Thursday, Can Fite Biopharma Ltd (CANF:TLV) closed at 242.10, 10.05% above the 52 week low of 220.00 set on Dec 18, 2017.
52-week range
Today
220.00Dec 18 2017432.80Jan 30 2018
Open252.80
High252.80
Low238.30
Bid240.00
Offer242.10
Previous close240.20
Average volume233.38k
Shares outstanding39.96m
Free float39.53m
P/E (TTM)--
Market cap95.02m ILS
EPS (TTM)-0.5635
ILS
Data delayed at least 20 minutes, as of Jun 21 2018 15:24 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.